The primary objective of this study is to assess the efficacy of varenicline in reducing the
proportion of heavy drinking days during the last 8 weeks of treatment in subjects with
alcohol dependence confirmed by Diagnostic and Statistical Manual of Mental Disorders-IV-Text
Revision (DSM-IV-TR) criteria and who frequently consume 10 or more drinks per drinking day
for men and 8 or more drinks for women (designated as "very heavy" drinkers).
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)